The Food and Drug Administration posted its latest warning letters including multiple ex-US OTC drug firms found in violation of manufacturing regulations as House Republicans criticized its foreign facility inspection work.
The Energy and Commerce Committee’s Oversight and Investigations Subcommittee on 6 February conducted a hearing as subcommittee chair Morgan Griffith,...






